Maternal Near Miss guidelines is designed for the program managers at different levels of public health system.to provide quality services and identify the best practices.
Uterus Transplantation Utx (obstetric and gynecology) D.A.B.M
Is the surgical procedure whereby a healthy uterus is transplanted into an organism of which the uterus is absent or diseased.
As part of normal mammalian sexual reproduction, a diseased or absent uterus does not allow normal embryonic implantation, effectively rendering the female infertile.
This phenomenon is known as Absolute Uterine Factor Infertility (AUFI).
Uterine transplant is a potential treatment for this form of infertility.
Uterus is a dynamic, complex organ. It is hugely blood-flow dependent.
More than 116,000 Number of men, women and children on the national transplant waiting list as of August 2017.
33,611 transplants were performed in 2016.
20 people die each day waiting for a transplant.
every 10 minutes another person is added to the waiting list.
Uterine prolapse (also called descensus or procidentia) means the uterus has descended from its normal position in the pelvis farther down into the vagina.Cervicopexy is fertility conserving surgical management of prolapse.
OSCE REVISION IN OBSTETRICS AND GYNECOLOGY 2015,NEARLY COVERING COURSE CURRICULUM .Prepared by Dr Manal Behery.Professor of OB&Gyne .Faculty of medicine,Zagazig University
Uterus Transplantation Utx (obstetric and gynecology) D.A.B.M
Is the surgical procedure whereby a healthy uterus is transplanted into an organism of which the uterus is absent or diseased.
As part of normal mammalian sexual reproduction, a diseased or absent uterus does not allow normal embryonic implantation, effectively rendering the female infertile.
This phenomenon is known as Absolute Uterine Factor Infertility (AUFI).
Uterine transplant is a potential treatment for this form of infertility.
Uterus is a dynamic, complex organ. It is hugely blood-flow dependent.
More than 116,000 Number of men, women and children on the national transplant waiting list as of August 2017.
33,611 transplants were performed in 2016.
20 people die each day waiting for a transplant.
every 10 minutes another person is added to the waiting list.
Uterine prolapse (also called descensus or procidentia) means the uterus has descended from its normal position in the pelvis farther down into the vagina.Cervicopexy is fertility conserving surgical management of prolapse.
OSCE REVISION IN OBSTETRICS AND GYNECOLOGY 2015,NEARLY COVERING COURSE CURRICULUM .Prepared by Dr Manal Behery.Professor of OB&Gyne .Faculty of medicine,Zagazig University
This presentation is all about the epidemiology of stillbirths, in India. It talks about the different challenges in controlling the stillbirths and the strategies of controlling it. The INAP guideline of Government of India, which is a stepping stone for controlling stillbirths in India, is also discussed here.
Recurrent pregnancy loss is a significant redroductive medical problem, influencing 2%–5% of couples. ... Throughout the years, proof based medications, for example, surgical correction of uterine abnormalities or asprin and heparin for antiphospholipid syndrome have improved the results for couples with repetitive pregnancy loss.
Embryo implantation in the region of a previous caesarean section scar is a rare but potentially catastrophic complication of a previous cesarean birth.
Antenatal care is the routine health control of presumed healthy pregnant women without symptoms (screening), in order to diagnose diseases or complicating obstetric conditions without symptoms and to provide information about lifestyle, pregnancy and delivery.
This presentation has the measures to be taken for the safety of patients. It covers the 6 goals
Goal 1: Identify patients correctly
Goal 2: Improve effective communication
Goal 3: Improve the safety of high-alert medications
Goal 4: Ensure safe surgery
Goal 5: Reduce the risk of health care-associated infections
Goal 6: Reduce the risk of patient harm resulting from falls
This presentation is all about the epidemiology of stillbirths, in India. It talks about the different challenges in controlling the stillbirths and the strategies of controlling it. The INAP guideline of Government of India, which is a stepping stone for controlling stillbirths in India, is also discussed here.
Recurrent pregnancy loss is a significant redroductive medical problem, influencing 2%–5% of couples. ... Throughout the years, proof based medications, for example, surgical correction of uterine abnormalities or asprin and heparin for antiphospholipid syndrome have improved the results for couples with repetitive pregnancy loss.
Embryo implantation in the region of a previous caesarean section scar is a rare but potentially catastrophic complication of a previous cesarean birth.
Antenatal care is the routine health control of presumed healthy pregnant women without symptoms (screening), in order to diagnose diseases or complicating obstetric conditions without symptoms and to provide information about lifestyle, pregnancy and delivery.
This presentation has the measures to be taken for the safety of patients. It covers the 6 goals
Goal 1: Identify patients correctly
Goal 2: Improve effective communication
Goal 3: Improve the safety of high-alert medications
Goal 4: Ensure safe surgery
Goal 5: Reduce the risk of health care-associated infections
Goal 6: Reduce the risk of patient harm resulting from falls
Establishing Liability in Nursing Home Litigation & Common Challengesrogerweinberg
Maryland attorney Roger Weinberg outlines the primary steps in establishing liability in long term care lawsuits - including nursing homes and assisted living facilities. What are their common defenses? Applicable safety regulations and needed documentation in nursing home negligence lawsuits.
Safety Monitoring and Reporting in Clinical Trials DIA Poster 2015KCR
How to get the plausible and precise safety data, maintaining the highest ethical standards
during clinical development?
KCR’s article presents critical points in safety monitoring and reporting at different stages of the clinical trial, as well the main difficulties faced by medical personnel and clinical team during their everyday practice.
Clinical Quality Measures: Measuring and monitoring clinical quality measures...Practice Fusion
Learn about:
1. CMS quality measures.
2. How to capture the data in Practice Fusion.
3. How this data can be used to earn incentive payments through quality reporting programs, including Meaningful Use and PQRS.
Objectives:
By the end of this call, you will be able to:
•Describe the processes of Root-Cause Analysis (RCA) and Multi-Incident Analysis (MIA) and their role in quality improvement
•Compare and contrast the different approaches to collecting hospital-acquired VTE data
•Identify an approach suitable for improving patient safety at your institution
Tasks for discussion week 91. Critique problem and mission stat.docxssuserf9c51d
Tasks for discussion week 9:
1. Critique problem and mission statements.
Team A:
Problem and mission statement: Correct procedure performed on patient by wrong doctor. The team identified the problem did not result in direct patient harm, but the process error had potential to cause direct patient harm. The mission statement included root cause analysis of the event with recommendations for improvement (monitor over 3-month period) and report findings with positive improvement at end of monitoring period.
Team B:
Problem and mission statement: Identified event as sentinel event. Noted full safety procedures in place over past five years. Mission to determine root causes of event and demonstrate successful plan for measurable improvement in three months or less.
Each team’s problem statement provides the appropriate and concise evaluation of the event. Team B’s mission statement provides for a time frame that is shorter for resolution given the gravity of the sentinel event.
2. Analyze team processes, review process flow chart and cause effect diagram, data
presented in two graphs and one table.
The flow chart with the notes on the procedures/practices and policies and the survey with staff with the nurse – physician interaction sharply contrasts with the results of the two bar graphs indicating positive results with training and sign off on universal protocols.
My take away from this is that being checked off on a process and going through the motions of a checkoff can be greatly influenced by the culture of the environment.
3. From the following selections which shaped the root cause discussions at both hospitals, teams selected the red highlighted statements as the two best root causes:
a. Chairman of Surgery is clearly the biggest contributor to the problem, and is the
single root cause, since he caused the near miss/sentinel event.
b. The culture in our OR suite is not conducive to patient safety.
c. The disruptive physician policy at our organization is ineffective in shaping
physician behavior. It needs to be re-written.
d. The Nursing/Physician relationships in our OR suites are compromised by poor
communication skills, ineffective conflict resolution, and no sense of team.
e. From CNO down through nurse managers, the nursing leadership at our
organization is ineffective
f. Educational offerings regarding the NPSGs, Universal Protocol, and Time-out
procedures are clearly lacking, and the single most important root cause of
these events.
g. The turnaround time between cases is reaching crisis proportions and surgical
volume is on a downward trend in both of these hospitals
4. Defend the teams’ position on the choice of these two; however, if you, as a case study team choose alternative root causes from this list given the data presented, defend that position.
Reflecting with my statement in question #2: training in procedures and checkoffs on procedures does not guarantee the outcomes. The culture of safety is related to the abi ...
Transforming Post-Acute Care with IMPACTCitiusTech
On October 6, 2014, a bipartisan bill on Improving Medicare Post-Acute Care Transformation (IMPACT) was signed. The IMPACT Act seeks to standardize assessments for vital care issues across the gamut of post-acute care (PAC) providers and builds a framework to ensure that the delivered care is mindful of the patient needs; thereby eliminating the current silo-focused approach to quality measurement and resource utilization.
What you need to know about the Pharmacovigilance guidelines for companies marketing drugs in India. A concise overview of the six modules in the Guidance Document and the responsibilities of the Marketing Authorization Holders.
Similar to Maternal Near Miss Operational Guidelines (20)
As a chronic disease it is prevalent in both developed and developing countries, and affecting children(10-20%) as well as adults(20-40%).Excess weight gain invites many associated diseases.
One in every ten people is suffering from kidney related diseases and Approx 1.50 lakh new kidney patients are added every year.Investigating an outbreak and to find the susceptibles in an area 'ii be a great achievement.
Worlds largest and unique early childhood development programme Introduced on 2nd October 1975 has so many positive outcomes till date but yet to achieve its objectives....
A Successful Project Proposal helps the Organisation to explain to the authority, why they are fit for a proposal,their plan of action,time-line for execution with Budget.
CHAPTER 1 SEMESTER V PREVENTIVE-PEDIATRICS.pdfSachin Sharma
This content provides an overview of preventive pediatrics. It defines preventive pediatrics as preventing disease and promoting children's physical, mental, and social well-being to achieve positive health. It discusses antenatal, postnatal, and social preventive pediatrics. It also covers various child health programs like immunization, breastfeeding, ICDS, and the roles of organizations like WHO, UNICEF, and nurses in preventive pediatrics.
Navigating Challenges: Mental Health, Legislation, and the Prison System in B...Guillermo Rivera
This conference will delve into the intricate intersections between mental health, legal frameworks, and the prison system in Bolivia. It aims to provide a comprehensive overview of the current challenges faced by mental health professionals working within the legislative and correctional landscapes. Topics of discussion will include the prevalence and impact of mental health issues among the incarcerated population, the effectiveness of existing mental health policies and legislation, and potential reforms to enhance the mental health support system within prisons.
ICH Guidelines for Pharmacovigilance.pdfNEHA GUPTA
The "ICH Guidelines for Pharmacovigilance" PDF provides a comprehensive overview of the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) guidelines related to pharmacovigilance. These guidelines aim to ensure that drugs are safe and effective for patients by monitoring and assessing adverse effects, ensuring proper reporting systems, and improving risk management practices. The document is essential for professionals in the pharmaceutical industry, regulatory authorities, and healthcare providers, offering detailed procedures and standards for pharmacovigilance activities to enhance drug safety and protect public health.
LGBTQ+ Adults: Unique Opportunities and Inclusive Approaches to CareVITASAuthor
This webinar helps clinicians understand the unique healthcare needs of the LGBTQ+ community, primarily in relation to end-of-life care. Topics include social and cultural background and challenges, healthcare disparities, advanced care planning, and strategies for reaching the community and improving quality of care.
The Importance of Community Nursing Care.pdfAD Healthcare
NDIS and Community 24/7 Nursing Care is a specific type of support that may be provided under the NDIS for individuals with complex medical needs who require ongoing nursing care in a community setting, such as their home or a supported accommodation facility.
India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...Kumar Satyam
According to TechSci Research report, "India Clinical Trials Market- By Region, Competition, Forecast & Opportunities, 2030F," the India Clinical Trials Market was valued at USD 2.05 billion in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 8.64% through 2030. The market is driven by a variety of factors, making India an attractive destination for pharmaceutical companies and researchers. India's vast and diverse patient population, cost-effective operational environment, and a large pool of skilled medical professionals contribute significantly to the market's growth. Additionally, increasing government support in streamlining regulations and the growing prevalence of lifestyle diseases further propel the clinical trials market.
Growing Prevalence of Lifestyle Diseases
The rising incidence of lifestyle diseases such as diabetes, cardiovascular diseases, and cancer is a major trend driving the clinical trials market in India. These conditions necessitate the development and testing of new treatment methods, creating a robust demand for clinical trials. The increasing burden of these diseases highlights the need for innovative therapies and underscores the importance of India as a key player in global clinical research.
The dimensions of healthcare quality refer to various attributes or aspects that define the standard of healthcare services. These dimensions are used to evaluate, measure, and improve the quality of care provided to patients. A comprehensive understanding of these dimensions ensures that healthcare systems can address various aspects of patient care effectively and holistically. Dimensions of Healthcare Quality and Performance of care include the following; Appropriateness, Availability, Competence, Continuity, Effectiveness, Efficiency, Efficacy, Prevention, Respect and Care, Safety as well as Timeliness.
Medical Technology Tackles New Health Care Demand - Research Report - March 2...pchutichetpong
M Capital Group (“MCG”) predicts that with, against, despite, and even without the global pandemic, the medical technology (MedTech) industry shows signs of continuous healthy growth, driven by smaller, faster, and cheaper devices, growing demand for home-based applications, technological innovation, strategic acquisitions, investments, and SPAC listings. MCG predicts that this should reflects itself in annual growth of over 6%, well beyond 2028.
According to Chris Mouchabhani, Managing Partner at M Capital Group, “Despite all economic scenarios that one may consider, beyond overall economic shocks, medical technology should remain one of the most promising and robust sectors over the short to medium term and well beyond 2028.”
There is a movement towards home-based care for the elderly, next generation scanning and MRI devices, wearable technology, artificial intelligence incorporation, and online connectivity. Experts also see a focus on predictive, preventive, personalized, participatory, and precision medicine, with rising levels of integration of home care and technological innovation.
The average cost of treatment has been rising across the board, creating additional financial burdens to governments, healthcare providers and insurance companies. According to MCG, cost-per-inpatient-stay in the United States alone rose on average annually by over 13% between 2014 to 2021, leading MedTech to focus research efforts on optimized medical equipment at lower price points, whilst emphasizing portability and ease of use. Namely, 46% of the 1,008 medical technology companies in the 2021 MedTech Innovator (“MTI”) database are focusing on prevention, wellness, detection, or diagnosis, signaling a clear push for preventive care to also tackle costs.
In addition, there has also been a lasting impact on consumer and medical demand for home care, supported by the pandemic. Lockdowns, closure of care facilities, and healthcare systems subjected to capacity pressure, accelerated demand away from traditional inpatient care. Now, outpatient care solutions are driving industry production, with nearly 70% of recent diagnostics start-up companies producing products in areas such as ambulatory clinics, at-home care, and self-administered diagnostics.
1. Dr Rajesh Kumar Ludam
P.G Student
Maternal Near Miss
Operational Guidelines
2. Outline Of Presentation
Introduction
Purpose Of The Guidelines
Definition and Rationale
Process of MNM-R
Steps for Diagnosis and Notification
Implementation Plan and Tools
Monitoring and Evaluation
Annexes
3. Introduction
Maternal mortality is a critical indicator to
assess a health care system.
Traditionally, the criteria of choice for
evaluating medical and systemic causes.
Near Miss cases are more common than
maternal deaths.
A more reliable quantitative analysis
provide a comprehensive profile of the health
system functioning.
The operational guidelines is designed for use
by program managers at different levels of
4. Purpose Of The Guideline
To identify technical and non-technical
causes of MNM
To identify health system response to
maternal emergencies
To identify gaps and contextualise
corrective measures to be taken
To provide regular feedback and response
to achieve the goals
Identify best practices
5.
6.
7. DEFINITION-: A Woman Who Survives Life
Threatening Conditions during Pregnancy, Abortion,
and Childbirth or within 42 Days of Pregnancy
Termination, irrespective of Receiving Emergency
Medical/Surgical Interventions, is called Maternal
Near Miss.
Advantage over MDR-:
More common than Maternal Deaths
Yields valuable information regarding severe
morbidity
Less threatening to providers
One can learn from the women themselves
Free lessons and opportunities to improve the
8. PROCESS of MNM-R
a) Notification (MO/HOD-if case meets inclusion
criteria)
b) Data Transmission (Institution to district to
state )
c) Review (Institutional & district level)
d) Analysis & Feedback for initiating necessary
action.
9. Diagnosing MNM
Inclusion Criteria-:Critically ill pregnant,
labouring, post-partum and post-abortal
women admitted to notified health institutions.
Criteria for identifying and notifying the
MNM case-:the following criteria (minimum
three from each category) must be met with:
1) Clinical findings (either symptoms or signs),
2) Investigations
3) Interventions
Or Any single criteria which signifies cardio
respiratory collapse (indicated by a heart
10. The clinical findings, investigations and
interventions have been put under three
broad categories-:
1) Pregnancy specific obstetric and
medical disorders,
2) Pre-existing disorders aggravated
during pregnancy,
3) Accidental / Incidental disorders in
pregnancy.
These broader categories have further
been segregated under different clinical
13. Investigation would aim to document the frequency
and nature at hospital level and to evaluate the
level of care at maternal life-saving emergency
services.
This will also provide the gaps for corrective actions
to be taken at various levels.
There are two formats in which the data need to be
entered –
1. Facility based Maternal Near Miss Review
(FBMNM-R ) form – Annexure 2
2. MNM-R case register – details of columns to be
made in the register – Annexure 3
14. Implementation plan of MNM-R
Implemented in selected well performing medical
colleges or tertiary centres.
Then to extend it to District hospitals/other FRUs.
In order to initiate MNM-R in a State the following
steps have to be undertaken-:
- Policy decision on Implementation of the program
by the State
- Notification of institutions to conduct MNM-R
- Provision of adequate budget and timely release
- Sensitization of State Program Officers
- Training of faculty and staff
- Printing of different formats
15. The Committees under MNM-R
The Committees are-:
1. Facility Based Maternal Death/ Near Miss
Review Committee (FBMNM-R Committee)
2. District level CS/CMO Maternal death/ Near Miss
Review Committee (DBMNM-R Committee)
The review will focus on-:
a) Circumstances under which the woman received
care
b) Cause of Maternal Near Miss
c) Steps that are required to prevent such
morbidities in future
16. The Committees -:
- Review MNM cases and share findings for
corrective action
- Make recommendations
- infrastructural strengthening,
- human resource availability,
- strengthen protocols and competence of
staff,
- ensure adequate Supplies and Equipment
- Analysis & Feedback - detected gaps, identified
best practices, corrective measures to be
17. Roles and Responsibilities of Nodal
Officers
State Nodal Officer (SNO)-:
Identifying the level and names of the health
facility
Collect relevant data district-wise/institution-
wise and carry out detailed analysis
Ensuring availability of different formats and
other requisite tools before initiation of
program
Priority action and timeline for the gaps
identified under MNM and periodic review of
progress
Nominate the district nodal officers
Provision of adequate budget and timely
release
18. District Nodal Officer (DNO)
District RCH Officer can be designated as the
District Nodal Officer.
1. Maintain the line list of facility based MNM cases,
data entry in the district; and ensure FBMNM-R at
the district level
2. Organize monthly District level MNM-R meetings;
maintain the minutes of meetings; follow up on
actions to be taken and prepare the Action Taken
Report
3. Participate in meetings of the State Level Task-
force and follow up on specific recommendations.
4. Undertake planning and budget estimates for
MNM-R in the district.
5. To make available the necessary equipment/
19. Medical Superintendent/ In-charge of Health
Facility
- Nominate FNO for the MNM-R program
- Form MNM-R Committee(may include Staff of
OBGYN, Anaesthesia, Nursing, Blood Bank,
Other relevant individuals)
- Forwarding the MNM-R tool with case sheet to
district CMO/CIVIL SURGEON within a week
- Taking local corrective actions as per MNM-R
findings
20. Facility Nodal Officer (FNO)
- Ensuring all cases of MNM are reported
- Preparing meeting calendar and calling the committee
on a designated day and date
- Review of MNM cases in MDR committee
- Send the report and its findings to district CMHO/ Civil
Surgeon
- Attend MDR/ MNM review meetings at district
HOD Obstetrics / Duty Medical Officer
- Identify MNM as per the indicated criteria and record in
the relevant register
- Complete FBMNM-R form and send to the MNM-R
Nodal officer of the facility within 48 hours of patients
discharge
- ENSURING NO CHANGES ARE MADE ON THE CASE
SHEET
- To ensure MNM-R formats are filled in before discharge
22. Monitoring and Evaluation
Indicators for Monitoring
1. Total Number of MNM cases in the reporting month
2. MNM cases reviewed by CMHO
3. Out of total MNM cases indicate the number against
following complication:
a. PPH
b. Eclampsia
c. Anemia
d. Septic Abortion
e. others
4. Type of gaps identified after review
5. Status of corrective action taken for the gaps
identified
37. Last Words……
With the observed decline in maternal
mortality, analysis of well defined near-miss
cases ‘ll be a more sensitive measure of the
standard of obstetric care.
Incorporation of near-misses into maternal
death enquiries would strengthen these audits
by allowing for more rapid reporting ,
reinforcing lessons learnt, establishing
requirement for intensive care.